Stock listing

ERNA Stock Price, News, Filings & Events — Ernexa Therapeutics Inc.

Selected listing: ERNA · NASDAQ · USD · US

This page tracks Ernexa Therapeutics Inc.'s ERNA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERNA:NASDAQ. ERNA:NASDAQ is the stock-level entry point for investors researching Ernexa Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ernexa Therapeutics Inc. is a public company traded under the ticker ERNA in the American market. The company has a market capitalization of approximately $4.58 million. Ernexa Therapeutics focuses on developing innovative therapeutic solutions.

ERNA:NASDAQUSDUSUpdated September 11, 2026
Ernexa Therapeutics Inc. logo
Ticker
ERNA:NASDAQ
Asset type
Stock
Market cap
$6.8M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Ernexa Therapeutics Inc. ERNA:NASDAQ stock context

This page tracks Ernexa Therapeutics Inc.'s ERNA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following ERNA:NASDAQ. ERNA:NASDAQ is the stock-level entry point for investors researching Ernexa Therapeutics Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Ernexa Therapeutics Inc. is a public company traded under the ticker ERNA in the American market. The company has a market capitalization of approximately $4.58 million. Ernexa Therapeutics focuses on developing innovative therapeutic solutions.

Latest news from Ernexa Therapeutics Inc.

All Ernexa Therapeutics Inc. news →

Research Ernexa Therapeutics Inc.

Alternate listings